NovaBiotics Announces First Patient Enrollment into the Cysteamine Domain of REMAP-CAP
/PRNewswire/ -- NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies for life-threatening and...
Source: prnewswire.com